Measurable residual disease in hematologic malignancies: a biomarker in search of a standard
Summary: Over the past decade, measurable residual disease (MRD) has emerged as a critical tool for detecting and monitoring a variety of cancers, but particularly hematologic malignancies. The rapid adaptation of this novel approach to monitoring disease status is intuitively appealing: it offers s...
Zapisane w:
| Główni autorzy: | , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Elsevier
2025-08-01
|
| Seria: | EClinicalMedicine |
| Hasła przedmiotowe: | |
| Dostęp online: | http://www.sciencedirect.com/science/article/pii/S2589537025002809 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|